Results 201 to 210 of about 99,302 (260)

Immunological features of acquired pure red cell aplasia: Specific human leucocyte antigen alleles, signal transducer and activator of transcription 3 mutations and a unique T‐cell receptor beta motif

British Journal of Haematology, EarlyView.
Summary T‐cell abnormalities have been implicated in the pathogenesis of acquired pure red cell aplasia (PRCA), particularly in its major subtypes such as idiopathic PRCA, thymoma‐associated PRCA and large granular lymphocytic leukaemia (LGLL)–associated PRCA, and the precise details remain unclear.
Naruaki Yamashita, Toru Kawakami, Shuji Matsuzawa, Shotaro Miyairi, Masae Maruyama, Fumihiro Kawakami, Shunsuke Kojima, Ryu Yanagisawa, Yumiko Higuchi, Hideki Makishima, Hideyuki Nakazawa, Fumihiro Ishida   +11 more
wiley   +1 more source

The Medical Abnormality of Homosexuality [PDF]

, 2003
Flanagan, Michael Brendan
core   +1 more source

Perspectives on Pertussis Prevention

Acta Paediatrica, EarlyView.
Ulrich Heininger
wiley   +1 more source

Rapid generation of prion disease models using AAV‐delivered PrP variants in knockout mice

Brain Pathology, EarlyView.
We developed a rapid AAV‐based system to generate prion disease models in weeks rather than months. Following systemic AAV9P31 delivery of modified PrP to knockout mice, we achieved brain‐wide expression and successful propagation of both classical (RML) and atypical (GSS‐A117V) prion strains.
Maitena San‐Juan‐Ansoleaga, Eva Fernández‐Muñoz, Jorge M. Charco, Enric Vidal, Diego Herrero‐Martínez, Josu Galarza‐Ahumada, Cristina Sampedro‐Torres‐Quevedo, Samanta Giler, Mariví Geijo, Gloria González‐Aseguinolaza, Hasier Eraña, Joaquín Castilla   +11 more
wiley   +1 more source

Covalent drug discovery: Progress against key targets, emerging strategies and lessons learnt

British Journal of Pharmacology, EarlyView.
Abstract Covalent drug discovery is currently experiencing a boom in industrial and academic interest. To date, at least 75 covalent drugs have received regulatory approval, targeting both traditional target classes and more challenging proteins for which other approaches failed. In many cases, unique aspects of covalent targeting are essential for the
Charles P. Brown, Alan Armstrong, David J. Mann   +2 more
wiley   +1 more source

Successful liver transplantation from crossmatch-positive donors. [PDF]

, 1981
Iwaki, Y, Iwatsuki, S, Kano, T, Klintmalm, G, Koep, LJ, Starzl, TE, Weil, R   +6 more
core  

Hepatitis C virus and hepatitis B virus in indolent lymphomas: Prospective data from the international observational NF10 study

British Journal of Haematology, EarlyView.
Luca Arcaini, Michele Merli, Sara Rattotti, Maria Elena Nizzoli, Vittoria Tarantino, Chiara Consoli, Annalisa Talami, Roberta Murru, Marina Deodato, Emanuele Cencini, Francesca Re, Carlo Visco, Guilherme Duffles, Michele Spina, Ombretta Annibali, Alessandro Pulsoni, Andrés J. M. Ferreri, Caterina Stelitano, Elsa Pennese, Marzia Varettoni, Emilia Cappello, Gianmarco Favrin, Martina La Fauci, Luigi Marcheselli, Marco Paulli, Stefano Luminari   +25 more
wiley   +1 more source

Hepatitis B antigen and antibodies

, 1977
openaire   +1 more source

SUBDUE‐3: SUB‐urothelial DUrvalumab‐89zirconium injEction; a phase 0 biodistribution study protocol

BJU International, EarlyView.
Kevin G. Keane, Richard Gauci, Roslyn J. Francis, Andrew M. Scott, Cynthia Hawks, Andrisha‐Jade Inderjeeth, Ian D. Davis, Jayne Lim, Andrew Redfern, Dickon Hayne   +9 more
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

HEPATITIS-B ANTIBODY IN POLYMYALGIA RHEUMATICA

The Lancet, 1975
Thirteen patients with polymyalgia rheumatica (P.M.R.) were examined for evidence of viral infection. Hepatitis-B surface antibody (HBsAb) was detected in nine out of twelve patients tested prior to therapy. The antibody persisted up to six months in four patients but reverted to negative in the other five.
P A, Bacon, S M, Doherty, A J, Zuckerman
openaire   +2 more sources